ArticleScientific reports2025

Ropivacaine mitigates neuropathic pain by inhibiting the activation of the TRAF2/PI3K/Akt/NF-κB signaling pathway.

Liwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.